{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:06Z","timestamp":1790043726601,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10354-010-0850-x","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T07:47:42Z","timestamp":1294386462000},"page":"605-608","source":"Crossref","is-referenced-by-count":31,"title":["Neuropathic Gaucher disease","Neuronopathische Formen Morbus Gaucher"],"prefix":"10.1007","volume":"160","author":[{"given":"Gregory M.","family":"Pastores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"11","key":"850_CR1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archneur.1993.00540110088009","volume":"50","author":"RO Brady","year":"1993","unstructured":"Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol, 50(11): 1212\u20131224, 1993","journal-title":"Arch Neurol"},{"issue":"12","key":"850_CR2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archneur.1991.00530240075025","volume":"48","author":"RP Grewal","year":"1991","unstructured":"Grewal RP, Doppelt SH, Thompson MA, et al. Neurologic complications of non-neuronopathic Gaucher's disease. Arch Neurol, 48(12): 1271\u20131272, 1991","journal-title":"Arch Neurol"},{"issue":"5","key":"850_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1157\/13124962","volume":"131","author":"P Giraldo","year":"2008","unstructured":"Giraldo P, Capablo JL, Alfonso P, et al. Neurological manifestations in patients with Gaucher disease and in their relatives. Med Clin (Barc), 131(5): 175\u2013179, 2008","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"850_CR4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/mds.22538","volume":"24","author":"J DePaolo","year":"2009","unstructured":"DePaolo J, Goker-Alpan O, Samaddar T, et al. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism. Mov Disord, 24(11): 1571\u20131578, 2009","journal-title":"Mov Disord"},{"issue":"12","key":"850_CR5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME, et al. Parkinsonism among Gaucher disease carriers. J Med Genet, 41(12): 937\u2013940, 2004","journal-title":"J Med Genet"},{"issue":"2","key":"850_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","volume":"15","author":"DL Stone","year":"2000","unstructured":"Stone DL, Tayebi N, Orvisky E, et al. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat, 15(2): 181\u2013188, 2000","journal-title":"Hum Mutat"},{"issue":"5","key":"850_CR7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat, 29(5): 567\u2013583, 2008","journal-title":"Hum Mutat"},{"issue":"3","key":"850_CR8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","volume":"14","author":"UH Schueler","year":"2003","unstructured":"Schueler UH, Kolter T, Kaneski CR, et al. Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. Neurobiol Dis, 14(3): 595\u2013601, 2003","journal-title":"Neurobiol Dis"},{"issue":"1","key":"850_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","volume":"18","author":"D Pelled","year":"2005","unstructured":"Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, et al. Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol Dis, 18(1): 83\u201388, 2005","journal-title":"Neurobiol Dis"},{"issue":"3","key":"850_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab, 82(3): 192\u2013207, 2004","journal-title":"Mol Genet Metab"},{"issue":"44","key":"850_CR11","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","volume":"104","author":"IB Enquist","year":"2007","unstructured":"Enquist IB, Lo Bianco C, Ooka A, et al. Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci USA, 104(44): 17483\u201317488, 2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"850_CR12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","volume":"19","author":"Y Sun","year":"2010","unstructured":"Sun Y, Liou B, Ran H, et al. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet, 19(6): 1088\u20131097, 2010","journal-title":"Hum Mol Genet"},{"issue":"15","key":"850_CR13","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","volume":"19","author":"AM Vaccaro","year":"2010","unstructured":"Vaccaro AM, Motta M, Tatti M, et al. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting. Hum Mol Genet, 19(15): 2987\u20132997, 2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"850_CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","volume":"19","author":"J Blanz","year":"2010","unstructured":"Blanz J, Groth J, Zachos C, et al. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum Mol Genet, 19(4): 563\u2013572, 2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"850_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","volume":"33","author":"A Tylki-Szyma\u0144ska","year":"2010","unstructured":"Tylki-Szyma\u0144ska A, Vellodi A, El-Beshlawy A, et al. Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis, 33(4): 339\u2013346, 2010","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"850_CR16","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/fn.82.2.F163","volume":"82","author":"DL Stone","year":"2000","unstructured":"Stone DL, Carey WF, Christodoulou J, et al. Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed, 82(2): F163\u2013F166, 2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"850_CR17","doi-asserted-by":"crossref","unstructured":"Kraoua I, Sedel F, Caillaud C, et al. A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients. Brain Dev, 2010 Mar. 20. [Epub ahead of print]","DOI":"10.1016\/j.braindev.2010.02.005"},{"issue":"3","key":"850_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-2001-16611","volume":"32","author":"DE Bamiou","year":"2001","unstructured":"Bamiou DE, Campbell P, Liasis A, et al. Audiometric abnormalities in children with Gaucher disease type 3. Neuropediatrics, 32(3): 136\u2013141, 2001","journal-title":"Neuropediatrics"},{"issue":"5","key":"850_CR19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10545-007-0595-x","volume":"30","author":"EH Davies","year":"2007","unstructured":"Davies EH, Surtees R, DeVile C, et al. A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease. J Inherit Metab Dis, 30(5): 768\u2013782, 2007","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"850_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","volume":"31","author":"M Biegstraaten","year":"2008","unstructured":"Biegstraaten M, van Schaik IN, Aerts JM, et al. 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis, 31(3): 337\u2013349, 2008","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"850_CR21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol, 66(5): 571\u2013576, 2009","journal-title":"Arch Neurol"},{"issue":"2","key":"850_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","volume":"452","author":"K Kalinderi","year":"2009","unstructured":"Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett, 452(2): 87\u201389, 2009","journal-title":"Neurosci Lett"},{"issue":"17","key":"850_CR23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med, 361(17): 1651\u20131661, 2009","journal-title":"N Engl J Med"},{"issue":"2","key":"850_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lab.2004.03.013","volume":"144","author":"E Beutler","year":"2004","unstructured":"Beutler E, Beutler L, West C. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease. J Lab Clin Med, 144(2): 65\u201368, 2004","journal-title":"J Lab Clin Med"},{"issue":"2","key":"850_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","volume":"33","author":"G Bultron","year":"2010","unstructured":"Bultron G, Kacena K, Pearson D, et al. The risk of Parkinson's disease in type 1 Gaucher disease. J Inherit Metab Dis, 33(2): 167\u2013173, 2010","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"850_CR26","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","volume":"66","author":"V Koprivica","year":"2000","unstructured":"Koprivica V, Stone DL, Park JK, et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet, 66(6): 1777\u20131786, 2000","journal-title":"Am J Hum Genet"},{"issue":"3","key":"850_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1203\/01.PDR.0000049515.79882.94","volume":"53","author":"JK Park","year":"2003","unstructured":"Park JK, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. Pediatr Res, 53(3): 387\u2013395, 2003","journal-title":"Pediatr Res"},{"issue":"5","key":"850_CR28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1399-0004.2001.590511.x","volume":"59","author":"R George","year":"2001","unstructured":"George R, McMahon J, Lytle B, Clark B, Lichtin A. Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation. Clin Genet, 59(5): 360\u2013363, 2001","journal-title":"Clin Genet"},{"issue":"4","key":"850_CR29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10545-006-0316-x","volume":"29","author":"H Michelakakis","year":"2006","unstructured":"Michelakakis H, Moraitou M, Dimitriou E, et al. Homozygosity for the double D409H+H255Q allele in type II Gaucher disease. J Inherit Metab Dis, 29(4): 591, 2006","journal-title":"J Inherit Metab Dis"},{"key":"850_CR30","doi-asserted-by":"crossref","unstructured":"Somaraju UR, Tadepalli K. Hematopoietic stem cell transplantation for Gaucher disease. Cochrane Database Syst Rev, (4): CD006974, 2008","DOI":"10.1002\/14651858.CD006974"},{"issue":"5","key":"850_CR31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","volume":"32","author":"A Vellodi","year":"2009","unstructured":"Vellodi A, Tylki-Szymanska A, Davies EH, et al. Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis, 32(5): 660\u2013664, 2009","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"850_CR32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/01.WNL.0000130191.31669.48","volume":"63","author":"PE Campbell","year":"2004","unstructured":"Campbell PE, Harris CM, Vellodi A. Deterioration of the auditory brainstem response in children with type 3 Gaucher disease. Neurology, 63(2): 385\u2013387, 2004","journal-title":"Neurology"},{"issue":"1","key":"850_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","volume":"153","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Wiggs EA, Eblan MJ, et al. Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. J Pediatr, 153(1): 89\u201394, 2008","journal-title":"J Pediatr"},{"issue":"5","key":"850_CR34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","volume":"64","author":"R Schiffmann","year":"2008","unstructured":"Schiffmann R, Fitzgibbon EJ, Harris C, et al. Randomized, controlled trial of miglustat in Gaucher's disease type 3. Ann Neurol, 64(5): 514\u2013522, 2008","journal-title":"Ann Neurol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0850-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0850-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:14:25Z","timestamp":1559927665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":34,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0850-x","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}